Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2020 Jun;40(6):755-759.
doi: 10.1016/j.rbmo.2020.04.003. Epub 2020 Apr 8.

COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine

Affiliations
Practice Guideline

COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine

Alberto Vaiarelli et al. Reprod Biomed Online. 2020 Jun.

Abstract

The COVID-19 pandemic is an unprecedented global situation. As assisted reproductive technology (ART) specialists, we should be cautious, carefully monitoring the situation while contributing by sharing novel evidence to counsel our patients, both pregnant women and would-be mothers. Time to egg collection and drop-out rates are critical parameters for scheduling treatments once the curve of infections has peaked and plateaued in each country. In order to reduce the values for these two parameters, infertile patients now require even more support from their IVF team: urgent oocyte collection for oncology patients must be guaranteed, and oocyte retrievals for women of advanced maternal age and/or reduced ovarian reserve cannot be postponed indefinitely. This document represents the position of the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) in outlining ART priorities during and after this emergency.

Keywords: Advanced maternal age; COVID-19; Oncology patients; Poor-prognosis patients; Reduced ovarian reserve; SARS-CoV-2.

PubMed Disclaimer

References

    1. Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nature Medicine. 2020;26:450–452. - PMC - PubMed
    1. Bedford J., Enria D., Giesecke J., Heymann D.L., Ihekweazu C., Kobinger G., Lane H.C., Memish Z., Oh M.D., Sall A.A., Schuchat A., Ungchusak K., Wieler L.H., Strategic W.H.O., TECHNICAL ADVISORY GROUP FOR INFECTIOUS, H. COVID-19: towards controlling of a pandemic. Lancet. 2020;395:1015–1018. doi: 10.1016/S0140-6736(20)30673-5. - DOI - PMC - PubMed
    1. Chen H., Guo J., Wang C., Luo F., Yu X., Zhang W., Li J., Zhao D., Xu D., gong Q., Liao J., Yang H., Hou W., Zhang Y. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809–815. - PMC - PubMed
    1. Cheng V.C., Lau S.K., Woo P.C., Yuen K.Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 2007;20:660–694. - PMC - PubMed
    1. De Santis L., Anastasi A., Cimadomo D., Klinger F.G., Licata E., Pisaturo V., Sosa Fernandez L., Scarica C. COVID-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency. Hum. Reprod. 2020 doi: 10.1093/humrep/deaa074. - DOI - PMC - PubMed

Publication types